Literature DB >> 16143678

Clozapine, agranulocytosis, and benign ethnic neutropenia.

S Rajagopal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16143678      PMCID： PMC1743348          DOI： 10.1136/pgmj.2004.031161

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  16 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Clozapine underutilization and discontinuation in African Americans due to leucopenia.

Authors:  Deanna L Kelly; Julie Kreyenbuhl; Lisa Dixon; Raymond C Love; Deborah Medoff; Robert R Conley
Journal:  Schizophr Bull       Date:  2006-12-14       Impact factor: 9.306

3.  Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.

Authors:  Charles M Richardson; Erica A Davis; Gopal R Vyas; Bethany A DiPaula; Robert P McMahon; Deanna L Kelly
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

4.  Changes for clozapine monitoring in the United States.

Authors:  T Bastiampillai; A Gupta; S K W Chan; S Allison
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

Review 5.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 6.  Benign ethnic neutropenia.

Authors:  Suheil Albert Atallah-Yunes; Audrey Ready; Peter E Newburger
Journal:  Blood Rev       Date:  2019-06-21       Impact factor: 8.250

7.  Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports.

Authors:  Emerson Arcoverde Nunes; Tatiana M N Rezende; Silvio L Morais; José A S Crippa; Serdar M Dursun; Glen B Baker; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2013-04

8.  Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.

Authors:  Kristin N Maher; Marcus Tan; Julia W Tossell; Brian Weisinger; Peter Gochman; Rachel Miller; Deanna Greenstein; Gerald P Overman; Judith L Rapoport; Nitin Gogtay
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03       Impact factor: 2.576

9.  There Is Life After the UK Clozapine Central Non-Rechallenge Database.

Authors:  Ebenezer Oloyede; Cecilia Casetta; Olubanke Dzahini; Aviv Segev; Fiona Gaughran; Sukhi Shergill; Alek Mijovic; Marinka Helthuis; Eromona Whiskey; James Hunter MacCabe; David Taylor
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

10.  Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.

Authors:  Oddur Ingimarsson; James H MacCabe; Magnús Haraldsson; Halldóra Jónsdóttir; Engilbert Sigurdsson
Journal:  BMC Psychiatry       Date:  2016-12-12       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.